SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing a massive surge after a strong earnings report that outperformed estimates, with the community celebrating the company's ability to capitalize on AI data center demand. Investors are actively discussing a significant sector rotation into semiconductors, with many focused on the stock shattering long-term resistance levels while shorts face an intense squeeze.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging to all-time highs as traders capitalize on massive spillover momentum from Intel's strong quarterly results and broader semiconductor industry demand. The community remains intensely focused on the AI infrastructure buildout, with bulls eyeing continued price expansion driven by strong sector leadership and persistent institutional accumulation.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Investors are actively debating the sustainability of the semiconductor rally, with many expressing frustration over the persistent strength in chip stocks that continues to punish bearish positions. The ongoing discussion centers on whether the sector is experiencing a classic speculative bubble fueled by extreme AI demand and institutional inflows, or if a sharp, imminent correction is inevitable as traders look for any signs of a market pivot.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending as investors aggressively position around the nuclear-AI nexus, fueled by a new federal initiative for space-based nuclear energy and the upcoming IPO of peer X-Energy. The community is focused on the stock's parabolic technical breakout, intense institutional accumulation, and the high-stakes battle to clear critical resistance levels as sentiment shifts to reflect nuclear power as a mandatory infrastructure requirement for AI compute.

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc. is surging after a federal jury ruled in its favor, awarding $420 million in damages regarding deceptive advertising and the use of bots by a rival, with potential for even greater profit disgorgement. Community sentiment is electric, with investors actively debating the long-term impact of the windfall on the companys cash position and the potential for a massive, multi-day short squeeze as traders monitor for after-hours momentum.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing significant momentum driven by the introduction of its new AGI CPU, a strategic shift that marks its transition from traditional IP licensing to direct silicon sales. The community is actively debating the sustainability of this aggressive repricing, with bullish investors highlighting the company's expanding role as a foundational AI infrastructure player, while skeptics warn of valuation risks following the rapid, volume-heavy breakout.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Investors are sharply divided over SOXL's historic, multi-week rally, with bulls citing a semiconductor "super-cycle" driven by insatiable AI infrastructure demand, while bears warn of a speculative "blow-off top" and unsustainable euphoria. Community discussions are dominated by the intense psychological battle between those riding the momentum to new highs and others aggressively hedging with inverse ETFs, all while monitoring key upcoming earnings catalysts.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is experiencing intense volatility as investors react to the Department of Justice's announcement to reclassify cannabis to Schedule III, a move expected to provide significant tax relief and improve banking access. While some in the community are celebrating this as a landmark shift, others are expressing frustration over the stock's sharp price swings and long-term dilution concerns, leading to active debates on whether this is a sustainable breakout or another 'sell-the-news' event.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as investors anticipate a major partnership announcement involving Ripple and prepare for industry events in Las Vegas, driving significant community excitement regarding its utility in real-time payroll and payment infrastructure. While some users express frustration over volatility and supply volume, bulls remain focused on the potential for institutional adoption and recent technical breakout patterns.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending as the community rallies around hopes of a major comeback, fueled by anticipation of Binance burn initiatives and potential exchange relistings. Investors are actively discussing the project's underdog status and speculative potential, with many pinning their hopes on future community-driven development and a return to past valuation levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Consensus Rating of "Moderate Buy" from Brokerages

Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, Marketbeat...

Assembly Biosciences (NASDAQ:ASMB) Price Target Raised to $43.00 at Guggenheim

Guggenheim raised their price objective on shares of Assembly Biosciences from $39.00 to $43.00 and gave the company a "buy" rating in a research note on Monday...

HC Wainwright Analysts Lower Earnings Estimates for ASMB

Assembly Biosciences, Inc. (NASDAQ:ASMB - Free Report) - HC Wainwright decreased their Q1 2026 earnings per share (EPS) estimates for Assembly Biosciences in a report released on Thursday, March...

Wall Street Zen Upgrades Assembly Biosciences (NASDAQ:ASMB) to Strong-Buy

Wall Street Zen upgraded shares of Assembly Biosciences from a "buy" rating to a "strong-buy" rating in a research report on Sunday...

Q1 Earnings Estimate for ASMB Issued By HC Wainwright

Assembly Biosciences, Inc. (NASDAQ:ASMB - Free Report) - Analysts at HC Wainwright issued their Q1 2027 earnings estimates for Assembly Biosciences in a report issued on Thursday, March 26th. HC Wainwright analyst P. Trucchio expects that the biopharmaceutical company will earn ($0.16) per share for...

Assembly Biosciences (NASDAQ:ASMB) Receives "Buy" Rating from HC Wainwright

HC Wainwright reaffirmed a "buy" rating and set a $50.00 price objective on shares of Assembly Biosciences in a research report on Thursday...

Assembly Biosciences (NASDAQ:ASMB) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Assembly Biosciences from a "hold" rating to a "buy" rating in a research report on Saturday...

Assembly Biosciences (NASDAQ:ASMB) Announces Quarterly Earnings Results, Beats Estimates By $2.99 EPS

Assembly Biosciences (NASDAQ:ASMB - Get Free Report) released its quarterly earnings data on Thursday. The biopharmaceutical company reported $2.48 EPS for the quarter, topping analysts' consensus estimates of ($0.51) by $2.99. The company had revenue of $42.47 million for the quarter, compared to...

Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates

Assembly Biosciences (ASMB) delivered earnings and revenue surprises of +586.28% and +300.65%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven analysts that are covering the company, MarketBeat reports. One...

Assembly Biosciences, Inc. is a biotechnology company that focuses on developing small molecule antiviral therapeutics for serious viral diseases. Its lead programs, ABI-5366 and ABI-1179, long-acting helicase-primase inhibitors, are in clinical development for recurrent genital herpes. The company is partnered with Gilead Sciences to advance current and future antiviral programs across herpesviruses, HBV, and HDV. Assembly Biosciences was founded in 2005 and is headquartered in South San Francisco, CA.

Current Price	$28.33
Prev Close	$28.30
Open	$28.33
Dividend Yield	0.00%
50-Day Moving Average	$28.55
Beta	1.10
Avg. Volume	75,924.92
PE Ratio	-15.39

52-Week High	$39.71
52-Week Low	$10.41
Market Capitalization	$448.91M
EPS (Annual)	-$0.5461
Price to Book	2.17
Revenue Per Employee	$990,452.06

ASMB
Assembly Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ASMB News

ASMBAssembly Biosciences Inc